Faculty profile

Andrew Mendlowitz

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Andrew Mendlowitz

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Drugs Health Outcomes Health Policy Hepatitis B Pharmaceutical Pharmacoequity

Latest papers

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).
Implementation science communications · 2026
Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).
Implementation science communications · 2025
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age.
Paediatrics & child health · 2025

All 9 publications

Latest funding

Understanding the shifting landscape of Hepatitis B treatment in Canada
CIHR · 2026 · Principal investigator
$436,050
W-PREV: Integrating Precision Medicine and Feminist Principles for Comprehensive Women's Sexual Health Promotion and HIV/STBBI Prevention in Ontario
CIHR · 2024 · Co-investigator
$20,000
The Response of Provincial Health Systems to COVID-19: Service Provision and Costs Across Health Sectors, First Nations and other populations
CIHR · 2020 · Co-investigator
$393,753

All 4 grants and awards

9 publications.

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Mooney M, Weight C, Biondi MJ, Grebely J, Kronfli N, Barnett T, Bruneau J, Dunn K, Elakpa DN, Etherington C, Greenaway C, Martel-Laferrière V, Mendlowitz A, Taylor N, Fontaine G

Implementation science communications2026

DOI: 10.1186/s43058-026-01014-w PMID: 42310812

Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Mooney M, Weight C, Biondi MJ, Grebely J, Kronfli N, Barnett T, Bruneau J, Dunn K, Elakpa DN, Etherington C, Greenaway C, Martel-Laferrière V, Mendlowitz A, Taylor N, Fontaine G

Implementation science communications2025

DOI: 10.1186/s43058-025-00837-3 PMID: 41408357

Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age.

Biondi MJ, Flemming J, van Gennip J, Barnett T, Masterman C, Mendlowitz A, Mooney M, Fontaine G, Feld JJ

Paediatrics & child health2025

DOI: 10.1093/pch/pxaf012 PMID: 40917280

Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients.

Mandel E, Biondi MJ, Mendlowitz A, Maheandiran M, Hollingdrake E, Vanderhoff A, Wolfson-Stofko B, Capraru C, Feld JJ, Logan R

The Journal of clinical psychiatry2023

DOI: 10.4088/jcp.22m14623 PMID: 37530609

First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.

Bilinski A, Slimovitch R, Mendlowitz A, Feld JJ, Salomon JA

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

DOI: 10.1093/cid/ciad379 PMID: 37579207

"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs.

Cheung DC, Bremner KE, Tsui TCO, Croxford R, Lapointe-Shaw L, Giudice LD, Mendlowitz A, Perlis N, Pataky RE, Teckle P, Zeitouny S, Wong WWL, Sander B, Peacock S, Krahn MD, Kulkarni GS, Mulder C

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2022

DOI: 10.1016/j.jval.2022.03.019 PMID: 35527165

Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

Tsui TCO, Zeitouny S, Bremner KE, Cheung DC, Mulder C, Croxford R, Del Giudice L, Lapointe-Shaw L, Mendlowitz A, Wong WWL

CMAJ Open202210 citations

DOI: 10.9778/cmajo.20210328

Striving toward hepatitis C elimination in the era of COVID-19.

Lanièce Delaunay C, Greenwald ZR, Minoyan N, Artenie AA, Jeong D, Marathe G, Saeed YA, Kolla G, Kunden RD, Okwor CIA, Wallace HL, Mendlowitz A, Liu CH, Mazouz S, D'souza S, Perciani CT, Rheault M, Palmer MA, Palayew A, Abdelnabi MN, Cunningham EB

Canadian liver journal2021

DOI: 10.3138/canlivj-2020-0027 PMID: 35991473

Usage of primary and administrative data to measure the economic impact of quality improvement projects.

Mendlowitz A, Croxford R, MacLagan L, Ritcey G, Isaranuwatchai W

BMJ open quality2020First author

DOI: 10.1136/bmjoq-2019-000712 PMID: 32276970

Something wrong or missing on this profile? Suggest a correction

Andrew Mendlowitz

Research

Latest papers

Latest funding

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age.

Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients.

First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.

"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs.

Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

Striving toward hepatitis C elimination in the era of COVID-19.

Usage of primary and administrative data to measure the economic impact of quality improvement projects.

Understanding the shifting landscape of Hepatitis B treatment in Canada

W-PREV: Integrating Precision Medicine and Feminist Principles for Comprehensive Women's Sexual Health Promotion and HIV/STBBI Prevention in Ontario

The Response of Provincial Health Systems to COVID-19: Service Provision and Costs Across Health Sectors, First Nations and other populations

The Epidemiology and Economic Burden of Hepatitis C Viral infection in the First Nations Population in Ontario

Frequent collaborators

Tamara Barnett

Guillaume Fontaine

Cole Etherington

Carol Mulder

Kate Dunn

Julie Bruneau

Guillaume Fontaine

Nadine Kronfli

Lauren Lapointe-Shaw

Nathan Perlis

Stuart Peacock

Christina Greenaway

Stuart Peacock

Beate Sander

Andrew Mendlowitz

Gillian Kolla

Dahn Jeong

Wanrudee Isaranuwatchai

Stuart Peacock

George Tomlinson

Beate Sander

Beate Sander